| 1 | Service organisation |
| 1a | prehospital |
| 1b | hospital |
| 1c | community |
| 1d | new initiatives and developments |
| 2 | Ischemic stroke |
| 2a | acute management – treatment |
| 2b | acute management – diagnosis |
| 2c | acute management other |
| 3 | Haemorrhagic stroke |
| 3a | acute management – treatment |
| 3b | acute management – diagnosis |
| 3c | acute management – other |
| 4 | Diffuse cerebrovascular disease |
| 4a | vascular cognitive impairment |
| 4b | small vessel disease |
| 4c | other |
| 5 | Primary prevention |
| 5a | ischaemic |
| 5b | haemorrhagic |
| 5c | diffuse/other, eg small vessel disease |
| 6 | Secondary prevention |
| 6a | ischaemic |
| 6b | haemorrhagic |
| 6c | diffuse/other, eg small vessel disease |
| 7 | Stroke aetiology |
| 7a | atherosclerosis |
| 7b | small vessel disease |
| 7c | heart brain |
| 7d | other |
| 8 | Long-term consequences |
| 8a | cognitive |
| 8b | neuropsychiatric |
| 8c | functional |
| 8d | other |
| 9 | Rehabilitation |
| 10 | Stroke across people and populations |
| 10a | epidemiology |
| 10b | Low & Middle Income settings |
| 10c | sex differences |
| 10d | ethnic or regional/cultural differences |
| 10e | socioeconomic differences |
| 11 | Discovery science |
| 11a | preclinical |
| 11b | proteomics, metabolomics, lipidomics |
| 11c | pathology |
| 11d | genetics |
| 11e | clinical translation |
| 12 | Technologies |
| 12a | devices |
| 12b | imaging |
| 12c | robotics |
| 12d | Artificial Intelligence |
| 13 | Innovations in clinical research |
| 13a | Clinical trial design |
| 13b | use of disease registries |
| 13c | use of ‘big data’ |
| 13d | innovative approaches using genetics |
| 13e | Other |
| 14 | Other |
Call for Proposals – Topics
Call for Proposals - Topics
